Insuman Basal 40IU/ml Injection
Marketer
Sanofi India Ltd
Salt Composition
Insulin Isophane (40IU)
Overview Insuman Basal 40IU/ml Injection
Basal Insulin 40 IU/mL injection manages blood glucose in adults and children with type 1 and type 2 diabetes. This intermediate-acting insulin lowers blood sugar, mitigating the risk of diabetes-related complications. It's frequently used alongside rapid-acting insulin or oral hypoglycemics, administered subcutaneously as instructed by your healthcare provider. Discontinue use only under medical supervision; it’s a component of a comprehensive treatment plan incorporating diet, exercise, and weight management. Regular blood glucose monitoring and result tracking are crucial for dose optimization. Hypoglycemia (low blood sugar) is the most common adverse effect; proper dosing, consistent meals, and blood glucose monitoring are essential for prevention. Excessive alcohol intake also increases hypoglycemia risk. Injection site reactions (redness, swelling) may occur; repetitive injections in the same area can cause lipodystrophy (skin changes). Weight gain and edema (generalized swelling) are possible. Avoid use with existing hypoglycemia. Inform your doctor of any kidney, liver, or heart conditions before starting treatment. Pregnant or lactating individuals require individualized dosage adjustments.
Uses of Insuman Basal 40IU/ml Injection
High blood sugar condition
Major Benefits of Insuman Basal 40IU/ml Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
Common Side effects of Insuman Basal 40IU/ml Injection:
- Hypoglycemia (low blood glucose level)
How to use Insuman Basal 40IU/ml Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Insuman Basal 40IU/ml Injection works:
Basal insulin, Insuman Basal 40 IU/ml, exerts its effect within one to two hours post-injection. Mimicking the body's natural insulin, it promotes glucose uptake by muscle and adipose tissue, concurrently inhibiting hepatic glucose production. This mechanism contributes to glycemic control in patients with diabetes.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol and Insuman Basal 40IU/ml Injection should not be consumed together due to safety concerns.
PregnancySAFE IF PRESCRIBED
Insuman Basal 40 IU/mL injections are typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
During breastfeeding, Insuman Basal 40 IU/ml Injection presents a low risk. Research in humans indicates minimal transfer of the medication into breast milk, posing no apparent danger to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.
KidneyCAUTION
Individuals with kidney impairment should exercise caution when using Insuman Basal 40 IU/ml Injection. Dosage modification of Insuman Basal 40 IU/ml Injection may be necessary. Physician consultation is advised. Routine blood glucose level checks are recommended to guide dosage alterations.
LiverCAUTION
Individuals with hepatic impairment should use Insuman Basal 40 IU/mL Injection cautiously, potentially requiring a modified dosage. Physician consultation is advised. Consistent glucose monitoring is recommended to guide appropriate dose modifications.
What if you forget to take Insuman Basal 40IU/ml Injection :
NA
Facts to Know About Insuman Basal 40IU/ml Injection
| Label | Value |
|---|---|
| Chemical Category | Modified insulin |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Active Class | Neutral protamine Hagedorn (NPH) insulin |

